Entia Launches GROH(R) Product Line Into New Market Opportunity
14 Maggio 2014 - 10:48PM
Marketwired
Entia Launches GROH(R) Product Line Into New Market Opportunity
PORTLAND, OR--(Marketwired - May 14, 2014) - Entia Biosciences,
Inc. (OTCQB: ERGO), an authority on the clinical effects of
oxidative stress and free radical reactions, today announced a
partnership agreement with Tan Republic Franchise Company. This
important milestone and strategic partnership follows the release
of independent studies on the cellular protection benefits of the
potent antioxidant Ergothioneine. The GROH® Ergo Boost product
line, positioned for the professional salon and spa industry, is
rich in both Vitamin D and is an all-natural source of
Ergothioneine.
The $5 billion+ market of Tanning and Light Therapy in the US
includes more than 22,632 operators in the industry, in addition to
health clubs, spas and beauty salons that also provide tanning as
an added service. Concerns about the health risks associated with
UV tanning are resulting in increased consumer concern. Cell
protection is an important topic in this industry and Tan Republic
and many others in this market are looking to provide customers
with the latest in technology and innovation to improve the safety
and protection of their guests.
"Our GROH® product line provides targeted delivery of key
micronutrients directly to cells responsible for healthy skin,"
said Julia Perederiy Ph.D., Research and Development Scientist at
Entia Biosciences.
Entia Biosciences will continue to explore this secondary market
and continue to expand its products with the all-natural source of
Ergothioneine with the benefits of targeted nutrition and cellular
protection. The approach to cellular protection is reinforced in a
published study "The Unusual Amino Acid L-Ergothioneine is a
Physiologic Cytoprotectant" (1). Study authors stated,
"Ergothioneine absorbs UV radiation and prevents DNA breaks and
mutations. Ergothioneine may stimulate certain enzymes involved in
antioxidant response and repair mechanisms and also have a role in
cell proliferation. In addition, Ergothioneine protects against a
variety of other ROS and reactive nitrogen species providing
cytoprotection at multiple levels."
"We are excited to offer our customers cutting-edge products
like those produced by GROH®," said Ariel Peterson of Tan Republic.
"The cellular protection offered by GROH® products makes it an
ideal addition to our business, while its ability to repair damaged
cells ensures that we're offering customers the highest level of
innovation available in the market."
(1) Paul & Snyder, "The Unusual Amino Acid L-Ergothioneine
Is a Physiologic Cytoprotectant." (Cell Death and Differentiation
(2009), 1-7; www.nature.com/cdd)
About Tan Republic
Tan Republic is the largest chain of its type in Oregon and
Washington, with nearly 60 salon locations serving over 50,000
guests per month. Tan Republic is proud to provide both UV and
sunless tanning options, along with non-invasive spa services, in
an upscale, relaxed atmosphere.
About GROH®
Backed by scientific innovation and medical research, all GROH®
products and services contain the potent master antioxidant
L-Ergothioneine, naturally amplified Vitamin D2, and other
important micronutrients and co-factors found in plants and whole
foods. These nutrients are unlocked, enhanced, and formulated into
Ergo Boost Complex, which works with the body's biological systems
to fulfill the everyday nutritional needs that our modern
lifestyles fail to provide. With regular use, the GROH® Ergo Boost
product line has been shown to promote thicker, fuller hair and
lashes, healthier skin, and increased nail strength and growth. For
more information on the science behind this revolutionary new
approach to health and beauty, please visit www.myGROH.com.
About Entia Biosciences, Inc.
Entia is an authority on the clinical effects of oxidative
stress and free radical reactions and is bringing this expertise to
the fields of food science biotechnology and Nutrigenomics. The
Company identifies, scientifically validates, patents, and
commercializes solutions that address multi-billion dollar markets
for health, beauty and agriculture.
Forward-Looking Statements
Any statements contained in this press release that relate to
future plans, events or performance are forward-looking statements
that involve risks and uncertainties including, but not limited to,
the risks associated with the transaction described in this press
release, and other risks identified in the filings by Entia
Biosciences with the Securities and Exchange Commission. Further
information on risks faced by the Company and its shareholders are
detailed in the Form 10-K for the year ended December 31, 2013 and
in its subsequent Quarterly Reports on Form 10-Q. These filings are
or will become available on a website maintained by the Securities
and Exchange Commission at http://www.sec.gov. The information
contained in this press release is accurate as of the date
indicated. Actual results, events or performance may differ
materially. Entia does not undertake any obligation to publicly
release the result of any revision to these forward-looking
statements that may be made to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated
events.
For further information: Devin Andres COO 503-334-3575
Grafico Azioni Entia Biosciences (CE) (USOTC:ERGO)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Entia Biosciences (CE) (USOTC:ERGO)
Storico
Da Giu 2023 a Giu 2024
